{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:50:42Z","timestamp":1791010242612,"version":"4.1.0"},"reference-count":179,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":1742,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1038\/ki.2010.472","type":"journal-article","created":{"date-parts":[[2010,12,8]],"date-time":"2010-12-08T13:54:24Z","timestamp":1291816464000},"page":"599-612","source":"Crossref","is-referenced-by-count":136,"title":["New pathophysiological insights and treatment of ANCA-associated vasculitis"],"prefix":"10.1016","volume":"79","author":[{"given":"Benjamin","family":"Wilde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"van Paassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Witzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Willem Cohen","family":"Tervaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2010.472_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1994.239","article-title":"Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential","volume":"46","author":"Kallenberg","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.472_bb0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0020","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.1780330804","article-title":"Illustrated histopathologic classification criteria for selected vasculitis syndromes","volume":"33","author":"Lie","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0025","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/ki.1990.48","article-title":"Autoantibodies against myeloid lysosomal-enzymes in crescentic glomerulonephritis","volume":"37","author":"Tervaert","year":"1990","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.472_bb0030","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"Masi","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0035","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0002-9343(91)90074-8","article-title":"Detection of autoantibodies against myeloid lysosomal-enzymes \u2013 a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis","volume":"91","author":"Cohen Tervaert","year":"1991","journal-title":"Am J Med"},{"key":"10.1038\/ki.2010.472_bb0045","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Antineutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2010.472_bb0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000096960","article-title":"Mechanisms of vasculitis: how pauci-immune is ANCA-associated renal vasculitis?","volume":"105","author":"van Paassen","year":"2007","journal-title":"Nephron Exp Nephrol"},{"key":"10.1038\/ki.2010.472_bb0055","first-page":"433","article-title":"In vitro up-regulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener\u2019s granulomatosis and microscopic polyangiitis","volume":"17","author":"Muller Kobold","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1038\/ki.2010.472_bb0060","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1046\/j.1523-1755.2000.00073.x","article-title":"Proteinase 3: a cofactor for the binding of antineutrophil cytoplasm antibodies (ANCA) to endothelial cells?","volume":"57","author":"Tervaert","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.472_bb0065","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.2353\/ajpath.2009.090533","article-title":"Anti-neutrophil cytoplasmic antibody pathogenesis in small-vessel vasculitis: an update","volume":"175","author":"Gomez-Puerta","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1038\/ki.2010.472_bb0070","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1189\/jlb.0604319","article-title":"Constitutive membrane expression of proteinase 3 (PR3) and neutrophil activation by anti-PR3 antibodies","volume":"76","author":"van Rossum","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1038\/ki.2010.472_bb0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2249.1999.01043.x","article-title":"The activation of the neutrophil respiratory burst by anti-neutrophil cytoplasm autoantibody (ANCA) from patients with systemic vasculitis requires tyrosine kinases and protein kinase C activation","volume":"118","author":"Radford","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/ki.2010.472_bb0080","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2249.1994.tb06518.x","article-title":"Activated neutrophils express proteinase-3 on their plasma-membrane in-vitro and in-vivo","volume":"95","author":"Csernok","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/ki.2010.472_bb0085","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/ndt\/14.6.1366","article-title":"Pathophysiology of ANCA-associated glomerulonephritis","volume":"14","author":"Muller Kobold","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.472_bb0090","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/rheumatology\/37.8.901","article-title":"Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener\u2019s granulomatosis","volume":"37","author":"Muller Kobold","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1038\/ki.2010.472_bb0095","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/1529-0131(200006)43:6<1337::AID-ANR16>3.0.CO;2-M","article-title":"Treatment of rolling neutrophils with antineutrophil cytoplasmic antibodies causes conversion to firm integrin-mediated adhesion","volume":"43","author":"Radford","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0100","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1111\/j.1523-1755.2004.00640.x","article-title":"Membrane proteinase 3 expression and ANCA-induced neutrophil activation","volume":"65","author":"Schreiber","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.472_bb0105","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1002\/art.21773","article-title":"Mediation of endothelial cell damage by serine proteases, but not superoxide, released from antineutrophil cytoplasmic antibody-stimulated neutrophils","volume":"54","author":"Lu","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0110","first-page":"117","article-title":"Neutrophil-mediated damage to human vascular endothelium. Role of cytokine activation","volume":"142","author":"Westlin","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1038\/ki.2010.472_bb0115","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM198902093200606","article-title":"Tissue destruction by neutrophils","volume":"320","author":"Weiss","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.472_bb0120","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0006-291X(89)90068-5","article-title":"Free radicals inactivate human neutrophil elastase and its inhibitors with comparable efficiency","volume":"159","author":"Dean","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/ki.2010.472_bb0125","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2249.1993.tb08192.x","article-title":"Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener\u2019s granulomatosis","volume":"93","author":"Dolman","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/ki.2010.472_bb0130","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1084\/jem.187.4.497","article-title":"Wegener\u2019s granulomatosis: anti-proteinase 3 antibodies are potent inductors of human endothelial cell signaling and leakage response","volume":"187","author":"Sibelius","year":"1998","journal-title":"J Exp Med"},{"key":"10.1038\/ki.2010.472_bb0135","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1365-2249.1999.00799.x","article-title":"Anti-proteinase-3 (PR3) antibodies (C-ANCA) recognize various targets on the human umbilical vein endothelial cell (HUVEC) membrane","volume":"115","author":"De Bandt","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/ki.2010.472_bb0140","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-2249.1998.00597.x","article-title":"Detection of Fcgamma receptors on human endothelial cells stimulated with cytokines tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma)","volume":"112","author":"Pan","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/ki.2010.472_bb0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/ndt\/gfl555","article-title":"Up-regulation of adhesion molecule expression in glomerular endothelial cells by anti-myeloperoxidase antibody","volume":"22","author":"Nagao","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.472_bb0150","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1002\/1529-0131(200112)44:12<2851::AID-ART473>3.0.CO;2-2","article-title":"Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells","volume":"44","author":"Radford","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1189\/jlb.0104054","article-title":"ANCA induces beta(2) integrin and CXC chemokine-dependent neutrophil-endothelial cell interactions that mimic those of highly cytokine-activated endothelium","volume":"77","author":"Calderwood","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1038\/ki.2010.472_bb0160","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.it.2005.08.010","article-title":"Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection?","volume":"26","author":"Heeringa","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1038\/ki.2010.472_bb0165","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2010.472_bb0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0002-9440(10)62952-5","article-title":"Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha","volume":"167","author":"Huugen","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1038\/ki.2010.472_bb0175","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9440(10)62951-3","article-title":"The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies","volume":"167","author":"Xiao","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1038\/ki.2010.472_bb0180","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2353\/ajpath.2009.080458","article-title":"Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis","volume":"174","author":"Little","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1038\/ki.2010.472_bb0185","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood-2004-01-0267","article-title":"Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo","volume":"104","author":"Pfister","year":"2004","journal-title":"Blood"},{"key":"10.1038\/ki.2010.472_bb0190","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2249.2009.04072.x","article-title":"Anti-PR3 immune responses induce segmental and necrotizing glomerulonephritis","volume":"159","author":"Primo","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/ki.2010.472_bb0195","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1183\/09031936.00143308","article-title":"c-ANCA induce neutrophil-mediated lung injury: a model of acute Wegener\u2019s granulomatosis","volume":"36","author":"Hattar","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1038\/ki.2010.472_bb0200","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0463.2009.02478.x","article-title":"Fifty years of antineutrophil cytoplasmic antibodies (ANCA) testing: do we need to revise the international consensus statement on testing and reporting on ANCA?","volume":"117","author":"Cohen Tervaert","year":"2009","journal-title":"APMIS"},{"key":"10.1038\/ki.2010.472_bb0205","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.1780330829","article-title":"Association of autoantibodies to myeloperoxidase with different forms of vasculitis","volume":"33","author":"Tervaert","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0210","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM198806233182504","article-title":"Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis","volume":"318","author":"Falk","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.472_bb0215","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1172\/JCI114335","article-title":"Wegener\u2019s granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils","volume":"84","author":"Goldschmeding","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2010.472_bb0220","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1182\/blood.V74.6.1888.1888","article-title":"Wegener\u2019s granulomatosis autoantigen is a novel neutrophil serine proteinase","volume":"74","author":"Niles","year":"1989","journal-title":"Blood"},{"key":"10.1038\/ki.2010.472_bb0225","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/346520a0","article-title":"Wegener\u2019s autoantigen decoded","volume":"346","author":"Jenne","year":"1990","journal-title":"Nature"},{"key":"10.1038\/ki.2010.472_bb0230","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm.1874","article-title":"Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis","volume":"14","author":"Kain","year":"2008","journal-title":"Nat Med"},{"key":"10.1038\/ki.2010.472_bb0235","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nm968","article-title":"Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3","volume":"10","author":"Pendergraft","year":"2004","journal-title":"Nat Med"},{"key":"10.1038\/ki.2010.472_bb0240","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.it.2005.05.001","article-title":"Role of complementary proteins in autoimmunity: an old idea re-emerges with new twists","volume":"26","author":"McGuire","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1038\/ki.2010.472_bb0245","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-120-1-199401010-00003","article-title":"Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis","volume":"120","author":"Stegeman","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2010.472_bb0250","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199607043350103","article-title":"Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener\u2019s granulomatosis","volume":"335","author":"Stegeman","year":"1996","journal-title":"New Engl J Med"},{"key":"10.1038\/ki.2010.472_bb0255","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2169\/internalmedicine.42.771","article-title":"The relation between Staphylococcus aureus and Wegener\u2019s granulomatosis: current knowledge and future directions","volume":"42","author":"Popa","year":"2003","journal-title":"Intern Med"},{"key":"10.1038\/ki.2010.472_bb0260","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/ndt\/12.4.652","article-title":"Co-trimoxazole and Wegener\u2019s granulomatosis: more than a coincidence?","volume":"12","author":"Stegeman","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.472_bb0265","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/ard.52.2.115","article-title":"Occurrence of autoantibodies to human leucocyte elastase in Wegener\u2019s granulomatosis and other inflammatory disorders","volume":"52","author":"Tervaert","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/ki.2010.472_bb0270","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/art.20479","article-title":"Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis","volume":"50","author":"Wiesner","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0275","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0140-6736(93)91761-A","article-title":"Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy","volume":"342","author":"Dolman","year":"1993","journal-title":"Lancet"},{"key":"10.1038\/ki.2010.472_bb0280","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/art.20927","article-title":"Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: a long-term followup study","volume":"53","author":"Slot","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0285","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/archderm.1977.01640020047008","article-title":"Cutaneous manifestations of Wegener granulomatosis","volume":"113","author":"Hu","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1038\/ki.2010.472_bb0290","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1440-1797.2009.01086.x","article-title":"Review article: pathogenic role of complement activation in anti-neutrophil cytoplasmic auto-antibody-associated vasculitis","volume":"14","author":"Van Timmeren","year":"2009","journal-title":"Nephrology"},{"key":"10.1038\/ki.2010.472_bb0295","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1111\/j.1523-1755.2004.00632.x","article-title":"Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases","volume":"65","author":"Haas","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.472_bb0300","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1053\/ajkd.2000.17615","article-title":"ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits","volume":"36","author":"Haas","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2010.472_bb0305","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/ndt\/18.3.524","article-title":"Glomerular immune deposits are associated with increased proteinuria in patients with ANCA-associated crescentic nephritis","volume":"18","author":"Neumann","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.472_bb0310","first-page":"295","article-title":"De novo glomerulonephritis in patients during remission from Wegener\u2019s granulomatosis","volume":"38","author":"Andrassy","year":"1992","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.2010.472_bb0315","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/ki.1994.149","article-title":"Neutrophil activation in-vitro and in-vivo in Wegener\u2019s granulomatosis","volume":"45","author":"Brouwer","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.472_bb0320","first-page":"269","article-title":"Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression","volume":"48","author":"Allmaras","year":"1997","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.2010.472_bb0325","first-page":"243","article-title":"Crescentic glomerulonephritis in Wegener\u2019s granulomatosis: morphology, therapy, outcome","volume":"35","author":"Grotz","year":"1991","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.2010.472_bb0330","first-page":"435","article-title":"Wegener\u2019s granulomatosis: observations on 18 patients with severe renal disease","volume":"52","author":"Pinching","year":"1983","journal-title":"Q J Med"},{"key":"10.1038\/ki.2010.472_bb0335","first-page":"212","article-title":"Immunopathological studies of polyarteritis nodosa and Wegener\u2019s granulomatosis: a report of 43 patients with 51 renal biopsies","volume":"52","author":"Ronco","year":"1983","journal-title":"Q J Med"},{"key":"10.1038\/ki.2010.472_bb0340","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/ajkd.2003.50142","article-title":"Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity","volume":"41","author":"Vizjak","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2010.472_bb0345","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1136\/ard.60.12.1097","article-title":"Detection of immune deposits in skin lesions of patients with Wegener\u2019s granulomatosis","volume":"60","author":"Brons","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/ki.2010.472_bb0350","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2249.1992.tb05834.x","article-title":"Activation of complement in normal serum by hydrogen-peroxide and hydrogen peroxide-related oxygen radicals produced by activated neutrophils","volume":"90","author":"Shingu","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/ki.2010.472_bb0355","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0171-2985(96)80050-7","article-title":"Complement activation by myeloperoxidase products released from stimulated human polymorphonuclear leukocytes","volume":"195","author":"Vogt","year":"1996","journal-title":"Immunobiology"},{"key":"10.1038\/ki.2010.472_bb0360","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-3083.1976.tb00296.x","article-title":"Effects of granulocyte neutral proteases on complement components","volume":"5","author":"Johnson","year":"1976","journal-title":"Scand J Immunol"},{"key":"10.1038\/ki.2010.472_bb0365","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2353\/ajpath.2007.060573","article-title":"Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies","volume":"170","author":"Xiao","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1038\/ki.2010.472_bb0370","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1681\/ASN.2008050497","article-title":"C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis","volume":"20","author":"Schreiber","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.472_bb0375","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.ki.5002103","article-title":"Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice","volume":"71","author":"Huugen","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.472_bb0380","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/rheumatology\/ken035","article-title":"Venous thromboembolism in ANCA-associated vasculitis\u2013incidence and risk factors","volume":"47","author":"Stassen","year":"2008","journal-title":"Rheumatology"},{"key":"10.1038\/ki.2010.472_bb0385","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.it.2007.02.006","article-title":"Complement and coagulation: strangers or partners in crime?","volume":"28","author":"Markiewski","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1038\/ki.2010.472_bb0390","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1681\/ASN.2005091013","article-title":"T cells in crescentic glomerulonephritis","volume":"17","author":"Tipping","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.472_bb0395","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/rheumatology\/ken202","article-title":"Germinal centre-like structures in Wegener\u2019s granuloma: the morphological basis for autoimmunity?","volume":"47","author":"Mueller","year":"2008","journal-title":"Rheumatology"},{"key":"10.1038\/ki.2010.472_bb0400","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/ki.1987.288","article-title":"T-cells and macrophages in rapidly progressive glomerulonephritis: clinicopathologic correlations","volume":"32","author":"Bolton","year":"1987","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.472_bb0405","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/0002-9343(83)91030-6","article-title":"Pulmonary vasculitis (Wegener\u2019s granulomatosis). Immunohistochemical study of T and B cell markers","volume":"74","author":"Gephardt","year":"1983","journal-title":"Am J Med"},{"key":"10.1038\/ki.2010.472_bb0410","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0091-6749(99)70434-3","article-title":"Differential B- and T-cell activation in Wegener\u2019s granulomatosis","volume":"103","author":"Popa","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1038\/ki.2010.472_bb0415","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2249.1993.tb05918.x","article-title":"Serum markers of T-cell activation in relapses of Wegener\u2019s granulomatosis","volume":"91","author":"Stegeman","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/ki.2010.472_bb0420","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780350914","article-title":"Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener\u2019s granulomatosis. Association with disease activity","volume":"35","author":"Schmitt","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0425","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2249.1991.tb05647.x","article-title":"Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener\u2019s granulomatosis and clinically related disorders","volume":"83","author":"Brouwer","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/ki.2010.472_bb0430","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1523-1755.2004.00534.x","article-title":"Treatment of refractory Wegener\u2019s granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients","volume":"65","author":"Schmitt","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.472_bb0435","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2249.2005.02731.x","article-title":"Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis","volume":"140","author":"Marinaki","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/ki.2010.472_bb0440","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/ndt\/gfl097","article-title":"Persistent T-cell activation and clinical correlations in patients with ANCA-associated systemic vasculitis","volume":"21","author":"Marinaki","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.472_bb0445","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/ndt\/gfn461","article-title":"CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener\u2019s granulomatosis","volume":"24","author":"Wilde","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.472_bb0450","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1002\/art.24747","article-title":"Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"60","author":"Abdulahad","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0455","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2796.2006.01698.x","article-title":"Effector memory T cells as driving force of granuloma formation and autoimmunity in Wegener\u2019s granulomatosis","volume":"260","author":"Lamprecht","year":"2006","journal-title":"J Intern Med"},{"key":"10.1038\/ki.2010.472_bb0460","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni0407-345","article-title":"TH-17 cells in the circle of immunity and autoimmunity","volume":"8","author":"Bettelli","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1038\/ki.2010.472_bb0465","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/art.23557","article-title":"Skewed distribution of Th17 lymphocytes in patients with Wegener\u2019s granulomatosis in remission","volume":"58","author":"Abdulahad","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0470","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1093\/ndt\/gfp783","article-title":"Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis","volume":"25","author":"Nogueira","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.472_bb0475","doi-asserted-by":"crossref","first-page":"e5287","DOI":"10.1371\/journal.pone.0005287","article-title":"CD45RC isoform expression identifies functionally distinct T cell subsets differentially distributed between healthy individuals and AAV patients","volume":"4","author":"Ordonez","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1038\/ki.2010.472_bb0480","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.4049\/jimmunol.160.7.3513","article-title":"IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages","volume":"160","author":"Jovanovic","year":"1998","journal-title":"J Immunol"},{"key":"10.1038\/ki.2010.472_bb0485","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-065X.2008.00637.x","article-title":"Human regulatory T cells: role in autoimmune disease and therapeutic opportunities","volume":"223","author":"Brusko","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1038\/ki.2010.472_bb0490","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/sj.ki.5001670","article-title":"Persistent expansion of CD4+ effector memory T cells in Wegener\u2019s granulomatosis","volume":"70","author":"Abdulahad","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.472_bb0495","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/art.22692","article-title":"Functional defect of circulating regulatory CD4+ T cells in patients with Wegener\u2019s granulomatosis in remission","volume":"56","author":"Abdulahad","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0500","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2567.2009.03213.x","article-title":"Patients with Wegener\u2019s granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells","volume":"130","author":"Morgan","year":"2010","journal-title":"Immunology"},{"key":"10.1038\/ki.2010.472_bb0505","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nri1786","article-title":"Lymphoid neogenesis in chronic inflammatory diseases","volume":"6","author":"Aloisi","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/ki.2010.472_bb0510","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1196\/annals.1361.042","article-title":"Is PR3-ANCA formation initiated in Wegener\u2019s granulomatosis lesions? Granulomas as potential lymphoid tissue maintaining autoantibody production","volume":"1051","author":"Voswinkel","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"10.1038\/ki.2010.472_bb0515","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1182\/blood-2005-05-1875","article-title":"Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway","volume":"107","author":"Csernok","year":"2006","journal-title":"Blood"},{"key":"10.1038\/ki.2010.472_bb0520","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.clim.2007.12.004","article-title":"Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener\u2019s granulomatosis","volume":"127","author":"Capraru","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1038\/ki.2010.472_bb0525","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/ard.2005.044909","article-title":"B lymphocyte maturation in Wegener\u2019s granulomatosis: a comparative analysis of VH genes from endonasal lesions","volume":"65","author":"Voswinkel","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/ki.2010.472_bb0530","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/ki.2008.99","article-title":"Compartment specific expression of dendritic cell markers in human glomerulonephritis","volume":"74","author":"Segerer","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.472_bb0535","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1093\/ndt\/gfp019","article-title":"Dendritic cells in renal biopsies of patients with ANCA-associated vasculitis","volume":"24","author":"Wilde","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.472_bb0540","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ki.2008.191","article-title":"Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis","volume":"74","author":"Steinmetz","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.472_bb0545","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1681\/ASN.2007060684","article-title":"Renal dendritic cells stimulate IL-10 production and attenuate nephrotoxic nephritis","volume":"19","author":"Scholz","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.472_bb0550","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1471-4906(02)02281-0","article-title":"Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?","volume":"23","author":"Lutz","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1038\/ki.2010.472_bb0555","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","article-title":"Netting neutrophils in autoimmune small-vessel vasculitis","volume":"15","author":"Kessenbrock","year":"2009","journal-title":"Nat Med"},{"key":"10.1038\/ki.2010.472_bb0560","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1038\/ki.2010.472_bb0565","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/416603a","article-title":"Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors","volume":"416","author":"Leadbetter","year":"2002","journal-title":"Nature"},{"key":"10.1038\/ki.2010.472_bb0570","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/art.23268","article-title":"Dysfunctional CD4+, CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells","volume":"58","author":"Yan","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0575","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.it.2009.07.011","article-title":"NETs: a new strategy for using old weapons","volume":"30","author":"Papayannopoulos","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1038\/ki.2010.472_bb0580","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","article-title":"Wegener\u2019s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years","volume":"98","author":"Fauci","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2010.472_bb0585","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/bmj.2.5091.265","article-title":"Giant-cell granuloma of the respiratory tract (Wegener\u2019s granulomatosis)","volume":"2","author":"Walton","year":"1958","journal-title":"Br Med J"},{"key":"10.1038\/ki.2010.472_bb0590","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","article-title":"Cyclophosphamide and cancer: golden anniversary","volume":"6","author":"Emadi","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1038\/ki.2010.472_bb0595","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.4049\/jimmunol.128.6.2453","article-title":"Suppression of human B lymphocyte function by cyclophosphamide","volume":"128","author":"Cupps","year":"1982","journal-title":"J Immunol"},{"key":"10.1038\/ki.2010.472_bb0600","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.472_bb0605","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.472_bb0610","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.472_bb0615","first-page":"S74","article-title":"Part 2: Synopsis of B-lymphocyte targeted therapy of ANCA-associated vasculitis","volume":"25","author":"Golbin","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1038\/ki.2010.472_bb0620","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/ard.2007.081661","article-title":"Long-term follow-up of relapsing\/refractory anti-neutrophil cytoplasm antibody associated vasculitis treated with the lymphocyte depleting antibody alemtuzumab (CAMPATH-1H)","volume":"67","author":"Walsh","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/ki.2010.472_bb0625","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","article-title":"EULAR recommendations for the management of primary small and medium vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/ki.2010.472_bb0630","first-page":"100","article-title":"Malignancies in Wegener\u2019s granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients","volume":"35","author":"Faurschou","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1038\/ki.2010.472_bb0635","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody associated vasculitis","volume":"150","author":"de Groot","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2010.472_bb0640","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.472_bb0645","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2369-11-12","article-title":"Interventions for renal vasculitis in adults. A systematic review","volume":"11","author":"Walters","year":"2010","journal-title":"BMC Nephrol"},{"key":"10.1038\/ki.2010.472_bb0655","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"Groot","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0660","doi-asserted-by":"crossref","first-page":"c100","DOI":"10.1159\/000089667","article-title":"Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis","volume":"102","author":"Koukoulaki","year":"2006","journal-title":"Nephron Clinical Practice"},{"key":"10.1038\/ki.2010.472_bb0665","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/ard.2006.060301","article-title":"Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide","volume":"66","author":"Stassen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/ki.2010.472_bb0670","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/ndt\/gfm780","article-title":"Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement","volume":"23","author":"Hu","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.472_bb0675","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegener\u2019s granulomatosis","volume":"352","author":"Stone","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.472_bb0680","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/art.21869","article-title":"Solid malignancies among patients in the Wegener\u2019s granulomatosis etanercept trial","volume":"54","author":"Stone","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0685","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1093\/ndt\/gfq187","article-title":"Prospective study of TNF{alpha} blockade with adalimumab in ANCA-associated systemic vasculitis with renal involvement","volume":"25","author":"Laurino","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.472_bb0690","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/art.23198","article-title":"Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients","volume":"58","author":"Ribi","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0695","first-page":"S52","article-title":"Churg Strauss syndrome \u2013 successful induction of remission with methotrexate and unexpected high cardiac and pulmonary relapse ratio during maintenance treatment","volume":"22","author":"Metzler","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1038\/ki.2010.472_bb0700","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","article-title":"Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity","volume":"93","author":"Jayne","year":"2000","journal-title":"QJM"},{"key":"10.1038\/ki.2010.472_bb0705","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/01.ASN.0000048716.42876.14","article-title":"15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy","volume":"14","author":"Birck","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.472_bb0710","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/ard.2008.092429","article-title":"Deoxyspergualin in relapsing and refractory Wegener\u2019s granulomatosis","volume":"68","author":"Flossmann","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/ki.2010.472_bb0715","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMc1001343","article-title":"Mixed lymphohematopoietic chimerism and response in Wegener\u2019s granulomatosis","volume":"362","author":"Bornhauser","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.472_bb0720","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/art.24637","article-title":"A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis","volume":"60","author":"Jones","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0725","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1749-4486.2009.01968.x","article-title":"B-cell depletion with rituximab for refractory head and neck Wegener\u2019s granulomatosis: a cohort study","volume":"34","author":"Martinez Del Pero","year":"2009","journal-title":"Clin Otolaryngol"},{"key":"10.1038\/ki.2010.472_bb0730","first-page":"S35","article-title":"A phase II study of interferon-alpha for the treatment of refractory Churg-Strauss syndrome","volume":"26","author":"Metzler","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1038\/ki.2010.472_bb0735","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.ejim.2008.12.008","article-title":"Omalizumab administration in Churg-Strauss syndrome","volume":"20","author":"Giavina-Bianchi","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.1038\/ki.2010.472_bb0740","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaci.2009.10.014","article-title":"Sustained response to mepolizumab in refractory Churg-Strauss syndrome","volume":"125","author":"Kahn","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1038\/ki.2010.472_bb0745","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/ard.2007.071936","article-title":"Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force","volume":"67","author":"Mukhtyar","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/ki.2010.472_bb0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/BOR.0b013e328011cb80","article-title":"Controversies in small vessel vasculitis \u2013 comparing the rheumatology and nephrology views","volume":"19","author":"Falk","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"10.1038\/ki.2010.472_bb0755","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1002\/art.23800","article-title":"Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts","volume":"58","author":"Pagnoux","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0760","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/art.20240","article-title":"Mycophenolate mofetil for remission maintenance in the treatment of Wegener\u2019s granulomatosis","volume":"51","author":"Langford","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0765","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1681\/ASN.V1091965","article-title":"Mycophenolate mofetil for maintenance therapy of Wegener\u2019s granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement","volume":"10","author":"Nowack","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.472_bb0770","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2010.1658","article-title":"Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial","author":"Hiemstra","year":"2010","journal-title":"JAMA"},{"key":"10.1038\/ki.2010.472_bb0775","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","article-title":"Azathioprine or methotrexate maintenance for ANCA-associated vasculitis","volume":"359","author":"Pagnoux","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.472_bb0780","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/rheumatology\/kem029","article-title":"Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener\u2019s granulomatosis","volume":"46","author":"Metzler","year":"2007","journal-title":"Rheumatology"},{"key":"10.1038\/ki.2010.472_bb0790","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/acr.20176","article-title":"The effects of duration of glucocorticoid therapy on relapse rate in anti-neutrophil cytoplasm antibody associated vasculitis: a meta-analysis","volume":"62","author":"Walsh","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1038\/ki.2010.472_bb0795","first-page":"24","article-title":"Interferon-alpha for maintenance of remission in Churg-Strauss syndrome: a long-term observational study","volume":"28","author":"Metzler","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1038\/ki.2010.472_bb0800","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jaci.2010.03.028","article-title":"Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome","volume":"125","author":"Kim","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1038\/ki.2010.472_bb0805","first-page":"S93","article-title":"Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis","volume":"24","author":"Mukhtyar","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1038\/ki.2010.472_bb0810","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.2006.062711","article-title":"EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"66","author":"Hellmich","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/ki.2010.472_bb0815","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/art.20234","article-title":"Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis","volume":"51","author":"Slot","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0820","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/archinte.1989.00390110055012","article-title":"Association between active Wegener\u2019s granulomatosis and anticytoplasmic antibodies","volume":"149","author":"Tervaert","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1038\/ki.2010.472_bb0825","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0140-6736(90)92205-V","article-title":"Prevention of relapses in Wegener\u2019s granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre","volume":"336","author":"Cohen Tervaert","year":"1990","journal-title":"Lancet"},{"key":"10.1038\/ki.2010.472_bb0830","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000072989","article-title":"ANCA testing in monitoring the activity of the disease","volume":"26","author":"Tervaert","year":"2003","journal-title":"Kidney Blood Press Res"},{"key":"10.1038\/ki.2010.472_bb0835","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.rdc.2007.09.001","article-title":"Targeting B lymphocytes as therapy for ANCA-associated vasculitis","volume":"33","author":"Golbin","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1038\/ki.2010.472_bb0840","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1600-6143.2007.01829.x","article-title":"CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects","volume":"7","author":"Kang","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.472_bb0845","doi-asserted-by":"crossref","first-page":"e2711","DOI":"10.1371\/journal.pone.0002711","article-title":"Immunological monitoring of renal transplant recipients to predict acute allograft rejection following the discontinuation of tacrolimus","volume":"3","author":"Kreijveld","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1038\/ki.2010.472_bb0850","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1212\/01.wnl.0000327341.89587.76","article-title":"Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy","volume":"72","author":"Stuve","year":"2009","journal-title":"Neurology"},{"key":"10.1038\/ki.2010.472_bb0855","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.0b013e3181beed38","article-title":"Iatrogenic immunosuppression with biologics in MS: expecting the unexpected?","volume":"73","author":"Stuve","year":"2009","journal-title":"Neurology"},{"key":"10.1038\/ki.2010.472_bb0860","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"key":"10.1038\/ki.2010.472_bb0865","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jaci.2008.01.002","article-title":"Costimulation blockade in autoimmunity and transplantation","volume":"121","author":"Vincenti","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1038\/ki.2010.472_bb0870","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/eurheartj\/ehp078","article-title":"From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells","volume":"30","author":"Leone","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1038\/ki.2010.472_bb0875","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1002\/art.24957","article-title":"Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study","volume":"60","author":"Morgan","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.472_bb0880","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/rheumatology\/kep130","article-title":"Reduced number of endothelial progenitor cells is predictive of early relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"48","author":"Zavada","year":"2009","journal-title":"Rheumatology"},{"key":"10.1038\/ki.2010.472_bb0885","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2249.2009.03885.x","article-title":"Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis","volume":"156","author":"Tervaert","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/ki.2010.472_bb0890","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jaut.2005.08.004","article-title":"BAFF is elevated in serum of patients with Wegener\u2019s granulomatosis","volume":"25","author":"Krumbholz","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1038\/ki.2010.472_bb0895","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/0003-4975(95)00618-U","article-title":"Anti-CD11b monoclonal antibody improves myocardial function after six hours of hypothermic storage","volume":"60","author":"Forbess","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"10.1038\/ki.2010.472_bb0900","doi-asserted-by":"crossref","unstructured":"Webster Angela C, Ruster Lorenn P, McGee R, Matheson Sandra L et al. Interleukin 2 receptor antagonists for kidney transplant recipients http:\/\/www.mrw.interscience.wiley.com\/cochrane\/clsysrev\/articles\/CD003897\/frame.html, accessed on 24 August 2010.","DOI":"10.1002\/14651858.CD003897.pub3"},{"key":"10.1038\/ki.2010.472_bb0905","doi-asserted-by":"crossref","unstructured":"Liu J, Wang L, Zhan S, Tan J et al. Daclizumab for relapsing remitting multiple sclerosis. http:\/\/www.mrw.interscience.wiley.com\/cochrane\/clsysrev\/articles\/CD008127\/frame.html, accessed on 24 August 2010.","DOI":"10.1002\/14651858.CD008127.pub2"},{"key":"10.1038\/ki.2010.472_bb0910","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/rheumatology\/kem022","article-title":"Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener\u2019s granulomatosis","volume":"46","author":"Popa","year":"2007","journal-title":"Rheumatology"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815548527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815548527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T12:18:05Z","timestamp":1685881085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815548527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":179,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0085253815548527"],"URL":"https:\/\/doi.org\/10.1038\/ki.2010.472","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}